Invesco's stake is below 5% and declining, indicating reduced conviction. Monitor for further reductions or a potential exit. The passive 13G status suggests no activist intent.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Nov 10 $345.80entry
- T+1 · 6d ago −0.90%α −2.22% · $342.69
- T+4 · todayOpen
- T+5 · in 3h Pending
- T+20 · in 22d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Invesco Ltd. filed an amended Schedule 13G for Charles River Laboratories, reporting beneficial ownership of 1,852,539 shares (3.9% of common stock) as of September 30, 2026. This is a routine passive stake update filed six days after the company's Q3 2026 earnings beat. The stake decreased from the prior filing (Invesco's initial 13G on August 13, 2026 did not disclose a percentage, but the current 3.9% is below the 5% threshold and represents a reduction from the prior filing's undisclosed level).
Key Financial Metrics
Key Facts
- Invesco Ltd. reported beneficial ownership of 1,852,539 shares of Charles River Laboratories common stock as of September 30, 2026.
- The stake represents 3.9% of shares outstanding, below the 5% threshold.
- This is an amendment to a Schedule 13G, indicating passive investment intent.
- The filing was made on November 10, 2026, six days after the company's Q3 2026 earnings beat.
- Invesco's prior 13G filing (August 13, 2026) did not disclose a percentage, but the current 3.9% is below 5% and represents a decrease from the prior filing's undisclosed level.
Financial Impact
Invesco holds 1,852,539 shares valued at approximately $72 million based on the $16.2B market cap and 47.8M shares outstanding (implied price ~$339/share).
Risk Factors
- Invesco may continue to reduce its position, creating selling pressure.
- The filing does not disclose the exact date of the stake measurement (September 30, 2026), so current holdings may differ.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0000914208-26-000392 |
| Document: 0000914208-26-000392-index.html | 0000914208-26-000392 |
| Document: 0000914208-26-000392.txt | 0000914208-26-000392 |
Track record
17 reports on CRL
3 of 3 bullish or bearish reports moved the stock their way by T+20. Best: +44.25% at T+60 after the Aug 5, 2026 report. 5 of 5 went positive at some point.
Filters
- Nov 16, 2026today SC 13G Neutral 4/10 Entry $333.18 Now $335.52 +0.70% settles Dec 15
- Nov 10, 20266d ago SC 13G/A Neutral 2/10 Viewing Entry $345.80 Now $335.52 −2.97% settles Dec 9
- Nov 9, 20267d ago 8-K Neutral 5/10 Entry $353.34 Now $335.52 −5.04% settles Dec 8
- Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $313.02 Now $335.52 +7.19% settles Dec 4
- Nov 4, 202612d ago 8-K Bullish 6/10 Entry $326.29 Now $335.52 +2.83% settles Dec 3
- Oct 26, 202621d ago Insider Cluster Neutral 2/10 Entry $358.84 Now $335.52 −6.50% settles Nov 24
- Oct 22, 202625d ago 144 Neutral 2/10 Entry $345.37 Now $335.52 −2.85% settles Nov 20
- Oct 21, 202626d ago Institutional Cluster Bullish 4/10 Entry $339.66 Now $335.52 −1.22% settles Nov 19
- Sep 24, 20267w ago 8-K Bullish 6/10 Entry $294.44 to $339.66 Now $335.52 +13.95% ▲ +15.36% +15.78% vs SPY
- Aug 27, 202611w ago Insider Cluster Neutral 3/10 Entry $291.50 to $294.59 Now $335.52 +15.10% ▲ +1.06% +1.55% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers